Department of Endocrine, Nutrition and Metabolic Diseases

Faculty and Staff

Staff

Patient Care Services

OPD service:

1. Endocrine, Nutrition and Metabolic diseases OPD (every Tuesday & Friday) at Calcutta School of Tropical Medicine.
2. Nutritional counselling, Monitoring and Medical Nutritional Therapy provided all outdoor patients treated in this Department as well as referred from other departments of this institution and other medical institutions.
3. Education and awareness regarding diabetes prevention, malnutrition prevention, living healthy life with diabetes, self-blood glucose monitoring, self-insulin administration techniques etc.
4. Treatment of diabetic complications like neuropathy, CVD, nephropathy, diabetic foot ulcer etc. with special care.

In patient service:

1. Admitting patients to Carmichael Hospital for Tropical Diseases.
2. Visiting referred cases by other departments of Calcutta School of Tropical Medicine.
3. Metabolic, Endocrinological and Nutritional management to patients treated under other departments.

Routine Indoor & OPD Cases (2025)

Ongoing Research Activities

Academic Trials

1. Comparison of low calorie high protein diet versus a Standard diet on glycaemic control among Type 2 Diabetic patients: A Non Randomized active controlled trial.
2. Effect of Lobeglitazone on arterial stiffness in comparison to Pioglitazone in patients with Type 2 diabetes: A pilot randomized controlled trial.
3. Effect of Saroglitazar on vascular stiffness in patients with Diabetic dyslipidemia: A pilot Randomized controlled trial.
4. Effect of Trelagliptin on vascular stiffness in comparison to Teneligliptin in type 2 diabetes mellitus: A pilot randomized controlled trial.
5. Effect of Levothyroxine replacement on changes in Renal function in Subclinical Hypothyroid patients with Type 2 Diabetes: An open label, Randomized controlled pilot trial.
6. Effects of Levothyroxine replacement therapy on insulin resistance markers in patients with Subclinical Hypothyroidism with Type 2 diabetes: An open label Randomized, controlled pilot trial.
7. Comparison of Little Millet based dinner versus a standard diet on glycaemic control among Type 2 diabetic patients from Eastern India: A randomized open label pilot trial.
8. Effect of Bempedoic acid on arterial stiffness in patients with Diabetic dyslipidemia: A pilot Randomized controlled trial.
9. Effect of once weekly Trelagliptin versus Once daily Teneligliptin on Cardiac Autonomic Neuropathy in Type 2 Diabetes Mellitus: A Randomized pilot, open label controlled trial.
10. Effect of once weekly Trelagliptin versus Once daily Teneligliptin on vascular stiffness in Type 2 Diabetes Mellitus: A Randomized pilot, open label controlled trial.

Multicentric Regulatory Trials

1. A Phase 3, multicenter, randomized, parallel-group study to compare the efficacy and safety of Alkem’s Semaglutide versus innovator Semaglutide (Ozempic, Novo Nordisk) in patients with Type 2 Diabetes Mellitus inadequately controlled on metformin.
2. A Phase 3, multicenter, randomized, parallel-group study to compare the efficacy and safety of Alkem’s Semaglutide vs innovator Semaglutide (Wegovy, Novo Nordisk) in patients with obesity.
3. A Phase 3, multicenter, randomized, parallel-group study to compare the efficacy and safety of Alkem’s Semaglutide versus innovator oral Semaglutide (Rybelsus, Novo Nordisk) in patients with Type 2 Diabetes Mellitus inadequately controlled on Metformin.

Publications

1. Khandelwal D, Naskar A, Borulkar D, Jadhav M, Bhushan S, Choudhari S, Patil S, Barkate H. Efficacy, Safety and Tolerability of Dapagliflozin and Teneligliptin Fixed dose Combination in patients with Type 2 Diabetes Mellitus inadequately controlled on Metformin monotherapy: A double blind, Four arm, Randomized Phase 3 Clinical study. Archives of Clinical and Biomedical Research. 2025;9(2025):440-447.
2. Mondal A, Naskar A, Choudhury B, Chakraborty S, Biswas T, Roy S. Evaluating the Performance and Safety of Large Language Models in Generating Type 2 Diabetes Mellitus Management Plans: A Comparative Study With Physicians Using Real Patient Records. eCollection. 2025 Mar. PMID: 40248538. doi:10.7759/cureus.80737.
3. Chatterjee R, Naskar A. A study to determine association between Monocyte HDL cholesterol ratio, Neutrophil to Lymphocyte ratio, Red Blood Cell Distribution Width (RDW) and Diabetic Retinopathy in a tertiary care centre in India. Bengal Physician Journal. 2025;10:5005.
4. Naskar A, Mondal A. Factors Associated with Microalbuminuria in Patients with Type 2 Diabetes: A Cross-sectional Study from Eastern India. Endocrinol Res Pract. 2024;28(4):224-228.
5. Naskar A, Mondal A, Chatterjee R, De D, Sasmit R. Assessing Liver Fibrosis in Type 2 Diabetes Mellitus Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: The Role of Non-invasive Scoring Systems and Associated Factors. Cureus. 16(6):e62405. doi:10.7759/cureus.62405.
6. Naskar A, Mondal A, Dhar I. Prevalence of iron deficiency in type 2 diabetes mellitus patients and its association with altered lipid profile. MGM Journal of Medical Sciences. 11(2):228-233, April-June 2024. doi:10.4103/mgmj.mgmj_140_24.
7. Mondal A, Naskar A, Siddiqi S, Bhosle D. Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial. Clinical Diabetes and Endocrinology. 2024;10:3. doi:10.1186/s40842-023-00161-6.
8. Chatterjee R, Naskar A, Samajdar SS, Mukherjee S, Joshi S, Karmakar PS. Blue Index as a Comprehensive, Patient-centered Assessment of Care in Diabetic Patients. JAPI. 2024. doi:10.59556/japi.72.0688.
9. Kumar Singh A, Sahay R, Sinha N, Tripathi S, Basu I, Bhalerao V, Patil M, Shrivastava G, Bhatia G, Pathak V, Dang A, Sarkar A. A randomized, double blind, active controlled trial assessing the efficacy and safety of a fixed dose combination (FDC) of Metformin hydrochloride 1000 mg ER, Sitagliptin phosphate 100 mg, and Dapagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial. Journal of Diabetes in Developing Countries. https://doi.org/10.1007/s13410-024-01321-9.